Today, Moscow became the venue for the National Industrial Forum focused on “Industry and national development goals”.

The forum aims at setting up a dialogue between businesses and the government, shaping a realistic industrial agenda with regard to state priorities and business needs. The bottomline is to get targeted support for projects of industrial companies, create proposals to the Russian government in order to achieve development goals in the Russian Federation.

Maxim Stetsyuk, CEO of NANOLEK, took part in the panel discussion “Pharmaceutical and medical industry” to discuss various topics with other participants: development of the “Pharma-2030” strategy, reinforcing export support, topical issues in socially significant diseases, current state support for industrial projects.

“Production of vaccines is a challenging business and intensive in terms of investments that pay off nor earlier than in 7, and on average in 10 years. Over the past 3-4 years, we have implemented joint projects with our foreign partner companies as part of “Pharma-2020” strategy. And these practical steps are extremely important since they made it possible to import modern multicomponent vaccines to Russia. Besides, we, as a local manufacturer, have gained priceless experience in the production of such vaccines at the level of global standards.

If it comes to discussing the “Pharma-2030” strategy, awareness of manufacturers of what vaccines will be needed in the coming years is an extremely important for state support of the vaccine track. In this case the local manufacturer, particularly NANOLEK, will assure to do its best to provide the Ministry of Health of Russia with vaccines required.”